Moderna (MRNA) Given 75% Probability to Develop COVID-19 Vaccine
Tembici raises $47M Series B to expand its fleet of electric bikes
Quest Sees Q2 EPS In Range Of Breakeven To Profitable On Testing Volume Recovery
Back In The Saddle Again: Growth And Momentum Equity Factors
This Analyst Thinks Menlo (MNLO) Stock Is Poised for Growth
Gilead’s next step on coronavirus
HCQ Misinformation Can Be Deadly: Let Patients Decide
First Trust rolls out cybersecurity and biotechnology ETFs on LSE
3 "Strong Buy" Penny Stocks That Could Go Boom
Convenient spit test helps women assess cancer risk from the comfort of their own homes
Moderna Embarks On Phase 2 Study Of Covid-19 Candidate; Shares Pop 11%
Quest’s Covid-19 Self-Collection Test Kit Gets FDA Nod For Emergency Use
Abiomed’s Heart Pump Gets FDA Emergency Use Status For Covid-19 Patients
U.S. awards new contract for potential COVID-19 vaccine
Eli Lilly Starts Dosing Patients In World's First Covid-19 Antibody Trial
3 'Strong Buy' Biotech Stocks Under $5 That Could Go Boom
Study shows hydroxychloroquine’s harmful effects on heart rhythm
Eli Lilly’s Taltz Injection Gets FDA Nod For Inflammatory Spine Arthritis Treatment
Immutep Surges In Pre-Market On Positive Efti Cancer Data
Drugmaker Abbvie Teams Up With Jacobio To Develop Cancer Inhibitor
Adaptimmune Spikes 127% Post-ASCO; Analyst Triples Price Target
Pfizer Loses 6% On Disappointing Ibrance Breast Cancer Outcome
Efgartigimod's Positive Data Is Good News for Momenta’s Nipocalimab
Chimeron Bio & George Mason NCBID partner on COVID-19 vaccine using ChaESARTM technology
Portfolio positioning for a recovery scenario
Coronavirus enters the vaccine debate
Bonhoeffer Fund 1Q20 Commentary: Combined Motor Holdings Case Study
Hydroxychloroquine combination risky for cancer patients with COVID-19: study
Novavax (NVAX) Stock Is a Winner, But How Much Higher Can It Go?
Oxford Biomedica signs COVID-19 vaccine supply deal with AZ
